Supplier | Hikma Pharmaceuticals USA Inc. |
---|---|
Availability Status | No Availability Issues Detected |
Status Description |
This product is either shipping normally or there is insufficient availability data to declare a disruption. |
QUMI Product Code | wm8tsjr (QuicksortRx Universal Medication Identifier) |
NDC | Package Count | Supplier | Description | Status | Updated |
---|---|---|---|---|---|
10 | Fresenius Kabi USA, LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
10 | Mylan Institutional LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
10 | Mylan Institutional LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
10 | Mylan Institutional LLC | Remifentanil 2 mg Vial [Ultiva] | ASHP Shortage + QS Availability Issues | 2024-06-28 |
RXCUI: | 1729584 |
---|---|
Dosage Form: | Vial |
Dosage Route: | INJECTABLE |
Strength: | 5 |
Measure: | mg |
ANDA: | ANDA210594 |
Generic Description: | REMIFENTANIL HCl |
DEA: | 2 |